Use Of Conjugates Of Fsh Receptor Ligands And Antitumour Agents For Therapy Of Cancer

  • Published: Jun 5, 2013
  • Earliest Priority: Feb 18 2008
  • Family: 13
  • Cited Works: 46
  • Cited by: 0
  • Cites: 8
  • Additional Info: Cited Works Published
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The present invention relates to a vascular endothelial FSH receptor ligand, in particular an anti-VE-FSHR antibody, which is coupled to an anti-tumour agent, in particular a toxin, for use in treating a condition associated with a tumor.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jun 5, 2013
  • Application: Feb 18, 2009
    EP EP 13157421 A
  • Priority: Feb 18, 2009
    EP EP 09711579 A
  • Priority: Feb 18, 2009
    EP EP 13157421 A
  • Priority: Feb 18, 2008
    EP EP 08305026 A

Download Citation


Sign in to the Lens

Feedback